[HTML][HTML] Endothelial dysfunction in COVID-19: an overview of evidence, biomarkers, mechanisms and potential therapies
The fight against coronavirus disease 2019 (COVID-19) caused by SARS-CoV-2 infection is
still raging. However, the pathophysiology of acute and post-acute manifestations of COVID …
still raging. However, the pathophysiology of acute and post-acute manifestations of COVID …
[HTML][HTML] Reviving the mutual impact of SARS-COV-2 and obesity on patients: From morbidity to mortality
Obesity-related metabolic dysfunction, endothelium imbalance, chronic inflammation,
immune dysregulation, and its comorbidities may all have a role in systemic inflammation …
immune dysregulation, and its comorbidities may all have a role in systemic inflammation …
[HTML][HTML] Immunoinflammatory, thrombohaemostatic, and cardiovascular mechanisms in COVID-19
The global coronavirus disease 2019 (COVID-19) pandemic has deranged the recent
history of humankind, afflicting more than 27 million individuals to date. While the majority of …
history of humankind, afflicting more than 27 million individuals to date. While the majority of …
COVID‐19 and acute coronary syndromes: From pathophysiology to clinical perspectives
L Esposito, FP Cancro, A Silverio… - Oxidative medicine …, 2021 - Wiley Online Library
Acute coronary syndromes (ACS) are frequently reported in patients with coronavirus
disease 2019 (COVID‐19) and may impact patient clinical course and mortality. Although …
disease 2019 (COVID‐19) and may impact patient clinical course and mortality. Although …
[HTML][HTML] Mechanisms contributing to adverse outcomes of COVID-19 in obesity
M Sudhakar, SB Winfred, G Meiyazhagan… - Molecular and cellular …, 2022 - Springer
A growing amount of epidemiological data from multiple countries indicate an increased
prevalence of obesity, more importantly central obesity, among hospitalized subjects with …
prevalence of obesity, more importantly central obesity, among hospitalized subjects with …
Association of body mass index and age with morbidity and mortality in patients hospitalized with COVID-19: results from the American Heart Association COVID-19 …
NS Hendren, JA De Lemos, C Ayers, SR Das, A Rao… - Circulation, 2021 - Am Heart Assoc
Background: Obesity may contribute to adverse outcomes in coronavirus disease 2019
(COVID-19). However, studies of large, broadly generalizable patient populations are …
(COVID-19). However, studies of large, broadly generalizable patient populations are …
COVID-19 severity in obese patients: Potential mechanisms and molecular targets for clinical intervention
With the global spread of SARS-CoV-2, millions of people have been affected leading to the
declaration of coronavirus disease 2019 (COVID-19) as a pandemic by the WHO. Several …
declaration of coronavirus disease 2019 (COVID-19) as a pandemic by the WHO. Several …
[HTML][HTML] The role of endothelium in COVID-19
The 2019 novel coronavirus, known as severe acute respiratory syndrome-coronavirus 2
(SARS-CoV-2) or coronavirus disease 2019 (COVID-19), is causing a global pandemic. The …
(SARS-CoV-2) or coronavirus disease 2019 (COVID-19), is causing a global pandemic. The …
COVID-19 and the heart and vasculature: novel approaches to reduce virus-induced inflammation in patients with cardiovascular disease
BS Kadosh, MS Garshick, J Gaztanaga… - … , and vascular biology, 2020 - Am Heart Assoc
The coronavirus disease 2019 (COVID-19) pandemic presents an unprecedented challenge
and opportunity for translational investigators to rapidly develop safe and effective …
and opportunity for translational investigators to rapidly develop safe and effective …
Obesity and Higher Risk for Severe Complications of Covid-19: What to do when the two pandemics meet
Abstract The coronavirus disease 2019 (COVID-19) pandemic has spread around the globe,
infecting more than ten million individuals, with more than 500,000 dead; about one half of …
infecting more than ten million individuals, with more than 500,000 dead; about one half of …